ZNF879 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.101100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.259200E-01
Normal-vs-Stage2
2.996100E-04
Normal-vs-Stage3
7.821600E-03
Normal-vs-Stage4
3.048600E-01
Stage1-vs-Stage2
2.213600E-01
Stage1-vs-Stage3
1.812950E-01
Stage1-vs-Stage4
7.363600E-01
Stage2-vs-Stage3
4.105600E-01
Stage2-vs-Stage4
4.598400E-01
Stage3-vs-Stage4
2.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.595900E-03
Normal-vs-AfricanAmerican
8.075900E-03
Normal-vs-Asian
2.008000E-02
Caucasian-vs-AfricanAmerican
9.494600E-01
Caucasian-vs-Asian
8.207800E-01
AfricanAmerican-vs-Asian
9.217200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.421750E-03
Normal-vs-Female
5.124400E-03
Male-vs-Female
1.279840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.056000E-01
Normal-vs-Age(41-60Yrs)
3.417000E-03
Normal-vs-Age(61-80Yrs)
1.063310E-03
Normal-vs-Age(81-100Yrs)
9.680900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.355400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.155200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.202400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.919800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.064800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.088000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.201400E-04
Normal-vs-Daily Drinker
8.0659000000094E-05
Normal-vs-Weekly Drinker
1.639460E-03
Normal-vs-Occasional Drinker
2.417700E-02
Normal-vs-Social Drinker
2.070100E-02
Non Drinker-vs-Daily Drinker
3.980600E-01
Non Drinker-vs-Weekly Drinker
3.156400E-01
Non Drinker-vs-Occasional Drinker
2.539800E-01
Non Drinker-vs-Social Drinker
3.665200E-01
Daily Drinker-vs-Weekly Drinker
7.939800E-02
Daily Drinker-vs-Occasional Drinker
8.979700E-02
Daily Drinker-vs-Social Drinker
1.401040E-01
Weekly Drinker-vs-Occasional Drinker
8.386400E-01
Weekly Drinker-vs-Social Drinker
9.769600E-01
Occasional Drinker-vs-Social Drinker
8.777800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.732240E-01
Normal-vs-Grade 2
9.545500E-02
Normal-vs-Grade 3
1.808840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.476430E-01
Grade 1-vs-Grade 3
1.159630E-01
Grade 1-vs-Grade 4
1.732240E-01
Grade 2-vs-Grade 3
6.688600E-01
Grade 2-vs-Grade 4
9.545500E-02
Grade 3-vs-Grade 4
1.808840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.122300E-03
Normal-vs-NonDiabetic
1.082790E-03
Diabetic-vs-NonDiabetic
6.456200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.279060E-03
Normal-vs-NoPancreatitis
1.703150E-03
Pancreatitis-vs-NoPancreatitis
2.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.123400E-03
Normal-vs-N1
2.416600E-04
N0-vs-N1
1.694360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.820400E-04
Normal-vs-TP53-NonMutant
7.296400E-02
TP53-Mutant-vs-TP53-NonMutant
5.097200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
